In response: Caution in prediction: Evaluating Zhang et al.'s approach to red blood cell transfusion risk
- PMID: 38488273
- DOI: 10.1111/trf.17731
In response: Caution in prediction: Evaluating Zhang et al.'s approach to red blood cell transfusion risk
Comment in
-
Reply.Transfusion. 2024 Mar;64(3):561-563. doi: 10.1111/trf.17733. Transfusion. 2024. PMID: 38488297 No abstract available.
Comment on
-
A transfusion risk stratification score to facilitate quality management in cardiopulmonary bypass.Transfusion. 2023 Aug;63(8):1495-1505. doi: 10.1111/trf.17487. Epub 2023 Jul 17. Transfusion. 2023. PMID: 37458390
References
REFERENCES
-
- Zhang Q, Gao Y, Tian Y, Gao S, Diao X, Ji H, et al. A transfusion risk stratification score to facilitate quality management in cardiopulmonary bypass. Transfusion. 2023;63:1495-1505.
-
- Nasa P, Jain R, Juneja D. Delphi methodology in healthcare research: how to decide its appropriateness. World J Methodol. 2021;11:116-129.
-
- Faraoni D, Levy JH, Albaladejo P, Samama CM, Groupe d'Interet en Hemostase P. Updates in the perioperative and emergency management of non-vitamin K antagonist oral anticoagulants. Crit Care. 2015;19:203.
-
- Carson JL, Stanworth SJ, Guyatt G, Valentine S, Dennis J, Bakhtary S, et al. Red blood cell transfusion: 2023 AABB international guidelines. Jama. 2023;330:1892.
-
- Zhang X, He Y, Xie X, Ji M, Ma X, Yu Z. Distribution of hemoglobin and prevalence of anemia in 10 ethnic minorities in China: a population-based, cross-sectional study. Medicine (Baltimore). 2017;96:e9286.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous
